Kiromic Biopharma, Inc. (KRBP) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18
	10-K	10-K	10-K	S-1/A
Operating expenses:
Research and development	11.4	5.1	1.2
General and administrative	13.9	14.1	2.5	1.8
Total operating expenses	25.7	19.2	3.7	3.2
Loss from operations	-25.7	-19.2	-3.7	-3.2

Other expense:
Total other expense	0.1	0.0	0.0
Net loss	-25.6	-19.2	-3.7	-3.8

Net loss per common share, basic	($2.26)	($4.42)	($1.39)	($1.33)
Net loss per common share, diluted	($2.26)	($4.42)	($1.39)	($1.33)

Weighted average common shares outstanding, basic	11.4	4.5	2.9	2.9
Weighted average common shares outstanding, diluted	11.4	4.5